LobbyingAssociation of Clinical Research Organizations lobbying by quarter
Association of Clinical Research Organizations's latest lobbying report covers Q2 2026, at $55K. The four quarters Q4 2025–Q3 2026 total $160K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Association of Clinical Research Organizations
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $160K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $50K | 2 |
| Q2 2025 | $50K | 2 |
| Q3 2025 | $50K | 2 |
| Q4 2025 | $50K | 2 |
| Q1 2026 | $55K | 2 |
| Q2 2026 | $55K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$670K · 19 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES19 reports
- SENATE19 reports
- Food & Drug Administration (FDA)13 reports
Firms it paid
| Firm | ||
|---|---|---|
| Washington Health Strategies Group | $610K | 13 quarters |
| Leavitt Partners | $90K | 2 quarters |
| McLeod Strategies | $60K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | McLeod Strategies | $10K |
| 07/15for Q2 | Leavitt Partners | $45K |
| 05/11for Q1 | McLeod Strategies | $10K |
| 04/20for Q1 | Leavitt Partners | $45K |
| 02/20for Q1 | Leavitt Partners | Under $5,000 |
| 01/21for Q4 2025 | McLeod Strategies | $10K |
| 01/21for Q4 2025 | Washington Health Strategies Group | $40K |
| 25/11/06for Q3 2025 | McLeod Strategies | $10K |
| 25/11/06for Q3 2025 | Washington Health Strategies Group | $40K |
| 25/08/05for Q2 2025 | McLeod Strategies | $10K |
| 25/08/05for Q2 2025 | Washington Health Strategies Group | $40K |
| 25/05/01for Q1 2025 | Washington Health Strategies Group | $40K |
| 25/05/01for Q1 2025 | McLeod Strategies | $10K |
| 25/01/30for Q4 2024 | Washington Health Strategies Group | $50K |
| 25/01/13for Q1 2025 | McLeod Strategies | Under $5,000 |
| 24/10/22for Q3 2024 | Washington Health Strategies Group | $50K |
| 24/07/30for Q2 2024 | Washington Health Strategies Group | $50K |
| 24/05/03for Q1 2024 | Washington Health Strategies Group | $50K |
| 24/02/05for Q4 2023 | Washington Health Strategies Group | $50K |
| 23/11/14for Q3 2023 | Washington Health Strategies Group | $50K |